Norwegian biotech company Hofseth starts clinical trials using farmed salmon oil as COVID-19 treatment
If phase two succeeds, the company will escalate the clinical trial to phase three with 600 patients.
If phase two succeeds, the company will escalate the clinical trial to phase three with 600 patients.